RxDoctor Payments Data
★ My doctorsLook up a doctor →

Pradeep Yadav, MD

Interventional Cardiology · Atlanta, GANPI 1366605552

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 67.8% of it on its own, with 14 other manufacturers making up the rest. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$655,586in general payments, 2019–2025

Across 968 payments — averaging $677.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$445K
  • Abbott$149K
  • Boston Scientific$40K
  • Shockwave Medical, Inc$12K
  • Livanova USA, Inc.$6K
  • Siemens Medical Solutions USA, Inc.$2K
  • plus $2K from 9 others
$2,793,399in research payments, 2019–2025

Across 256 payments — averaging $10,912 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$2.4M
  • Abbott$159K
  • Boston Scientific$103K
  • Medtronic$94K
  • Livanova USA, Inc.$19K
$3,600in ownership & investment interests, 2019–2025

Across 1 payment — averaging $3600.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Pi-cardia, Inc.$4K

What the payments were for

  • Consulting fees$391,93860%
  • Speaking & faculty fees$124,11919%
  • Grants$660%
  • Travel & lodging$109,45917%
  • Food & beverage$29,6845%
  • Education$370%
  • Other$2820%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences603$444,754
Abbott277$148,725
Boston Scientific42$39,594
Shockwave Medical, Inc7$12,063
Livanova USA, Inc.8$5,643
Siemens Medical Solutions USA, Inc.3$2,449
Medtronic(2 entities)19$1,774
Jenavalve Technology, Inc.1$328
Artivion, Inc.1$102
E.r. Squibb & Sons, L.L.C.2$50
Angiodynamics, Inc.1$50
W. L. Gore & Associates, Inc.1$16
Resmed Corp1$13
Baxter Healthcare1$12
Chiesi USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$655,586 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Medicare billing

Part B allowed, 2024
$267,930
Medicare patients
520
Services billed
911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$43,081
Furosemide53$206
Warfarin Sodium22$136
Prednisone49$104
Potassium Chloride17$82
Amoxicillin17$62
Metoprolol Tartrate13$46

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →